- Home
- LNTH vs NNI Comparison
LNTH vs NNI Comparison
Compare LNTH & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- NNI
- Stock Information
- Founded
- LNTH 1956
- NNI 1978
- Country
- LNTH United States
- NNI United States
- Employees
- LNTH 808
- NNI N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NNI Finance: Consumer Services
- Sector
- LNTH Health Care
- NNI Finance
- Exchange
- LNTH Nasdaq
- NNI Nasdaq
- Market Cap
- LNTH 3.8B
- NNI 4.7B
- IPO Year
- LNTH 2015
- NNI 2003
- Fundamental
- Price
- LNTH $56.28
- NNI $132.73
- Analyst Decision
- LNTH Buy
- NNI
- Analyst Count
- LNTH 6
- NNI 0
- Target Price
- LNTH $74.50
- NNI N/A
- AVG Volume (30 Days)
- LNTH 1.5M
- NNI 65.8K
- Earning Date
- LNTH 11-06-2025
- NNI 11-06-2025
- Dividend Yield
- LNTH N/A
- NNI 0.90%
- EPS Growth
- LNTH N/A
- NNI 116.62
- EPS
- LNTH 3.77
- NNI 9.04
- Revenue
- LNTH $1,520,653,000.00
- NNI $1,559,342,000.00
- Revenue This Year
- LNTH N/A
- NNI $12.03
- Revenue Next Year
- LNTH $2.25
- NNI $5.34
- P/E Ratio
- LNTH $14.86
- NNI $14.68
- Revenue Growth
- LNTH 5.75
- NNI 21.39
- 52 Week Low
- LNTH $47.25
- NNI $98.15
- 52 Week High
- LNTH $118.21
- NNI $136.17
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- NNI 61.65
- Support Level
- LNTH $56.03
- NNI $128.79
- Resistance Level
- LNTH $57.94
- NNI $133.58
- Average True Range (ATR)
- LNTH 1.56
- NNI 2.56
- MACD
- LNTH 0.39
- NNI 0.31
- Stochastic Oscillator
- LNTH 79.58
- NNI 89.58
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NNI Nelnet Inc.
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.